Professor Ian Frazer, director of the University of Queensland?s Centre for Immunology and Cancer Research (CICR), Australia, has been announced as a potential candidate for the Noble Prize Awards, due to his recent creation of the first and only vaccine against cervical cancer ? Gardasil.
Gardasil, which is distributed by Merck Sharp & Dohme, is now available in over 33 countries around the world. Gardasil is a ready-to-use, three-dose vaccine, and should be administered in three injections in the upper arm or upper thigh over a six-month period.
The following dosage schedule is recommended: first dose at elected date, second dose two months after the first dose, and the third dose should be administered six months after the first dose. The health care provider should inform the patient, parent or guardian that vaccination does not substitute routine cervical cancer screening. Women who receive Gardasil should continue to undergo cervical cancer screening per standard of care.